Literature DB >> 2164430

Treatment of a malignant pancreatic endocrine tumour secreting parathyroid hormone related protein.

D Wynick1, W A Ratcliffe, D A Heath, S Ball, M Barnard, S R Bloom.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164430      PMCID: PMC1663058          DOI: 10.1136/bmj.300.6735.1314

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  2 in total

Review 1.  Somatostatin and its analogues in the therapy of gastrointestinal disease.

Authors:  D Wynick; J M Polak; S R Bloom
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

2.  Somatostatin receptors in human endocrine tumors.

Authors:  J C Reubi; R Maurer; K von Werder; J Torhorst; J G Klijn; S W Lamberts
Journal:  Cancer Res       Date:  1987-01-15       Impact factor: 12.701

  2 in total
  6 in total

Review 1.  Somatostatin analog therapy in treatment of gastrointestinal disorders and tumors.

Authors:  Wouter W de Herder; Steven W J Lamberts
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

2.  Treatment of a pancreatic tumour secreting parathyroid hormone related protein.

Authors:  D Dodwell; H Gurney; H Scarffe; S Abbas
Journal:  BMJ       Date:  1990-06-23

Review 3.  Medical management of hypercalcaemia.

Authors:  S H Ralston
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

4.  Hypercalcemia and pancreatic endocrine neoplasia with elevated PTH-rP: report of two new cases and subject review.

Authors:  Susanna L Matsen; Charles J Yeo; Ralph H Hruban; Michael A Choti
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

5.  [Somatostatin in preoperative therapy and postoperative diagnosis of a patient with Verner Morrison syndrome].

Authors:  R J Weinel; C Neuhaus; J Stapp; H J Klotter; M E Trautmann; R Arnold; K Josef; M Rothmund
Journal:  Langenbecks Arch Chir       Date:  1992

6.  Parathyroid hormone-related peptide in pancreatic neuroendocrine tumours associated with hypercalcaemia.

Authors:  I M Papazachariou; I T Virlos; R C Williamson
Journal:  HPB (Oxford)       Date:  2001       Impact factor: 3.647

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.